Evidence map›Paper›PMID 19706711›Full record

ArticleJournal of virology2009

Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.

Yi Liu, Amanda Woodward, Haiying Zhu, Thomas Andrus, John McNevin, Jean Lee, James I Mullins, Lawrence Corey, M Juliana McElrath, Tuofu Zhu

Abstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Receptor binding domain based HIV vaccines.BioMed research international · 2015
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yi LiuDepartment of Microbiology, University of Washington, Seattle, WA 98109, USA.
Amanda Woodward
Haiying Zhu
Thomas Andrus
John McNevin
Jean Lee
James I Mullins
Lawrence Corey
M Juliana McElrath
Tuofu Zhu

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart · 1988 to 2026
$104.9M
Viral Determinants of HIV-1 Transmission in African HeterosexualsP01AI057005 · NIAID · UNIVERSITY OF WASHINGTON · PI COREY, LAWRENCE · 2003 to 2014
$20.5M
HIV-1 CELLULAR IMMUNITY IN EXPOSED SERONEGATIVESR01AI047086 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MCELRATH, MARGARET JULIANA · 2000 to 2010
$4.5M
Mucosal CTL Induction After HIV Exposure &VaccinationR37AI035605 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MCELRATH, MARGARET JULIANA · 1998 to 2007
$3.4M
Minimal Levels of HIV-1 in Vaccinated &Exposed PersonsR01AI055336 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, TUOFU · 2003 to 2007
$1.6M
Role of CD14+ Monocytes in HIV-1 InfectionR01AI049109 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, TUOFU · 2001 to 2005
$1.3M
SUPPRESSING HIV INFECTION IN EXPOSED SERONEGATIVE ADULTSR01AI045402 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, TUOFU · 1999 to 2003
$873k
Effect of DC-SIGNR Polymorphisms on HIV-1 InfectionR21AI056994 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, TUOFU · 2003 to 2003
$373k
CMIG FOR AIDS VACCINER01AI035605 · NIAID · UNIVERSITY OF WASHINGTON · PI MCELRATH, MARGARET JULIANA · 1994 to 1997
–
NIAID NIH HHS AI047086NIAID NIH HHS AI27757NIAID NIH HHS AI35605NIAID NIH HHS AI45402NIAID NIH HHS AI49109NIAID NIH HHS AI55336NIAID NIH HHS AI56994NIAID NIH HHS AI57005NIAID NIH HHS P01 AI057005NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI045402NIAID NIH HHS R01 AI047086NIAID NIH HHS R01 AI049109NIAID NIH HHS R01 AI055336NIAID NIH HHS R21 AI056994NIAID NIH HHS R37 AI035605
6 · The paper itself

Abstract

Understanding the mechanisms underlying potential altered susceptibility to human immunodeficiency virus type 1 (HIV-1) infection in highly exposed seronegative (ES) individuals and the later clinical consequences of breakthrough infection can provide insight into strategies to control HIV-1 with an effective vaccine. From our Seattle ES cohort, we identified one individual (LSC63) who seroconverted after over 2 years of repeated unprotected sexual contact with his HIV-1-infected partner (P63) and other sexual partners of unknown HIV-1 serostatus. The HIV-1 variants infecting LSC63 were genetically unrelated to those sequenced from P63. This may not be surprising, since viral load measurements in P63 were repeatedly below 50 copies/ml, making him an unlikely transmitter. However, broad HIV-1-specific cytotoxic T-lymphocyte (CTL) responses were detected in LSC63 before seroconversion. Compared to those detected after seroconversion, these responses were of lower magnitude and half of them targeted different regions of the viral proteome. Strong HLA-B27-restricted CTLs, which have been associated with disease control, were detected in LSC63 after but not before seroconversion. Furthermore, for the majority of the protein-coding regions of the HIV-1 variants in LSC63 (except gp41, nef, and the 3' half of pol), the genetic distances between the infecting viruses and the viruses to which he was exposed through P63 (termed the exposed virus) were comparable to the distances between random subtype B HIV-1 sequences and the exposed viruses. These results suggest that broad preinfection immune responses were not able to prevent the acquisition of HIV-1 infection in LSC63, even though the infecting viruses were not particularly distant from the viruses that may have elicited these responses.

Indexed as

Genetic VariationHIV Long-Term SurvivorsSexual PartnersCytotoxicity, ImmunologicHIV-1HIV InfectionsHIV SeronegativityHLA-B27 AntigenHumansLymphocyte ActivationMaleSexual BehaviorT-Lymphocytes, CytotoxicUnsafe SexHLA-B27 Antigen

Identifiers

PMID19706711
PMCPMC2753147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.